BJ Bioscience Inc. is a clinical stage biotechnology company dedicated to research and development of innovative drugs for unmet medical needs worldwide. It is founded by experts with many years of experience in research and development of innovative drugs and complementary expertise, including a review expert of National Key Innovative Drug R&D Projects, the National Health Commission of China. Based on its top-notch BJ-SIB bispecific antibody platform and trade secret protected antibody generation and screening technology, BJ Bioscience focuses its R&D on oncology, infectious and autoimmune diseases. Key members of the company's R&D team have many years of experience in R&D and management of antibody drugs from key national scientific research institutions, domestic and foreign pharmaceutical companies especially European and American multinational companies
With a global perspective of its R&D and strong capital support, BJ Bioscience has a global presence from the beginning of its inception, with R&D laboratories in both San Francisco, USA and Shanghai, China. Such global perspective and presence enables the company to realize globally the full range of talents, technology, management and capital market in the early stage of its entrepreneurship and lays a solid foundation for its global positioning and development.